Literature DB >> 35125729

Iatrogenic Immunodeficiency Associated Lymphoproliferative Disorder in Patients with Acute Lymphoblastic Leukemia:A Case Series.

Ashwini Ronghe1, George Abraham2, Jayashree Thorat2, Lingaraj Nayak2, Manju Sengar2, Tanuja Shet2, Sridhar Epari3, Sumeet Gujral3, Bhausaheb Bagal2, Avinash Bonda2, Neha Sharma2, Hasmukh Jain2.   

Abstract

Entities:  

Keywords:  Acute leukemia; Bone marrow pathology; Clinical aspects; Clinical hematology; Immunodeficiency; Lymphoproliferative disease

Year:  2021        PMID： 35125729      PMCID： PMC8804023          DOI： 10.1007/s12288-021-01491-0

Source DB:  PubMed          Journal:  Indian J Hematol Blood Transfus        ISSN： 0971-4502            Impact factor:   0.900


× No keyword cloud information.
  5 in total

1.  Therapy-related classical Hodgkin lymphoma after a primary haematological malignancy: a report on 13 cases.

Authors:  Morgane Cheminant; Lionel Galicier; Josette Brière; David Boutboul; Jean-Michel Micléa; Marie-Dominique Venon; Marie Robin; Catherine Thieblemont; Pauline Brice
Journal:  Br J Haematol       Date:  2012-06-26       Impact factor: 6.998

2.  Post-transplant lymphoproliferative disorder: a heterogeneous conundrum.

Authors:  Dennis D Weisenburger; Thomas G Gross
Journal:  Br J Haematol       Date:  2016-07-22       Impact factor: 6.998

3.  Brief report: reversible lymphomas associated with Epstein-Barr virus occurring during methotrexate therapy for rheumatoid arthritis and dermatomyositis.

Authors:  O W Kamel; M van de Rijn; L M Weiss; G J Del Zoppo; P K Hench; B A Robbins; P G Montgomery; R A Warnke; R F Dorfman
Journal:  N Engl J Med       Date:  1993-05-06       Impact factor: 91.245

4.  Epstein-Barr virus-positive B-cell lymphoproliferative disorders arising in immunodeficient patients previously treated with fludarabine for low-grade B-cell neoplasms.

Authors:  Lynne V Abruzzo; Cecilia M Rosales; L Jeffrey Medeiros; Francisco Vega; Rajyalakshmi Luthra; John T Manning; Michael J Keating; Dan Jones
Journal:  Am J Surg Pathol       Date:  2002-05       Impact factor: 6.394

5.  Cancer Therapy-associated Lymphoproliferative Disorders: An Under-recognized Type of Immunodeficiency-associated Lymphoproliferative Disorder.

Authors:  Sergio Pina-Oviedo; Roberto N Miranda; L Jeffrey Medeiros
Journal:  Am J Surg Pathol       Date:  2018-01       Impact factor: 6.394
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.